New diabetes clinical trial: A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI)
Published on: December 30, 2025 at 11:00PM
Conditions: Type 2 Diabetes
Interventions: Drug: Dapagliflozin (10Mg Tab) along with standard medical therapy; Drug: Empagliflozin (25 Mg Tab) along with standard medical therapy
Sponsors: Bhavya Bhavya, MD
Not yet recruiting
https://ift.tt/EoPZqsv
Conditions: Type 2 Diabetes
Interventions: Drug: Dapagliflozin (10Mg Tab) along with standard medical therapy; Drug: Empagliflozin (25 Mg Tab) along with standard medical therapy
Sponsors: Bhavya Bhavya, MD
Not yet recruiting
https://ift.tt/EoPZqsv
Comments
Post a Comment